There are many ways to kill people. Some powerful leaders and groups of the world view a majority of the worlds population as “useless eaters“. What to do with all those “useless eaters” ?
A preferred way to reduce the number of “useless eaters” and maintain plausible denial is the “slow kill”.
A new peer-reviewed study has raised significant concerns about the potential impact of COVID-19 mRNA vaccines on female fertility, using comprehensive population data from the Czech Republic.
In his recent video, Dr. John Campbell explores this landmark research and its implications for global reproductive health.
Key Findings from the Study
The study titled “Rates of Successful Conceptions According to COVID-19 Vaccination Status” analyzed data from 1.3 million Czech women aged 18 to 39 between January 2021 and December 2023. This is not a sample-based study but rather a near-total population analysis of childbearing-age women, making the findings especially robust.
The Most Striking Result:
Women vaccinated with mRNA COVID-19 vaccines had significantly lower rates of successful conception (defined as pregnancies resulting in live births) compared to unvaccinated women.
-
Successful conception rates in vaccinated women were up to 30% lower than in unvaccinated women.
-
In mid-2021, although 39% of women had been vaccinated, only 7% of successful conceptions occurred in vaccinated women: a 32% gap.
-
By 2022 and 2023, unvaccinated women consistently had 1.5 times higher conception rates than vaccinated women.
Total Fertility Rate in Decline
The national fertility rate in the Czech Republic dropped steadily during the study period:
-
2021: 1.83 births per 1,000 women
-
2022: 1.62
-
2023: 1.45
These numbers reflect a downward trend in births following the widespread rollout of mRNA vaccines, which includes Pfizer and Moderna (comprising 96% of doses given in the Czech Republic).
Visual Evidence and Methodology
The study used official national data comparing conception rates month by month, controlling for changes in vaccination rates over time. A graphic included in the study showed:
-
Red Line: All births
-
Blue Line: Births from unvaccinated women
-
Green Line: Births from vaccinated women
The gap between the blue and green lines was substantial throughout 2021 and remained noticeable into 2022 and 2023.
Biological Concerns: Exploring Plausible Mechanisms
Dr. Campbell emphasized that biological explanations must be prioritized over purely sociological ones. While declining birth rates have been observed in various countries post-pandemic (often attributed to economic uncertainty or social changes), this study raises concerns of direct biological effects from mRNA vaccines, such as:
-
Menstrual changes, including irregularities, pain, and altered cycles
-
Potential spike protein accumulation in reproductive organs
-
Endometrial disruption, which may interfere with embryo implantation
-
Reported impacts on ovarian follicles, possibly reducing ovulation
-
Immune-mediated rejection of early pregnancies due to systemic changes triggered by the vaccine
The Study’s Limitations and Scientific Caution
The authors themselves are cautious in drawing conclusions, noting the results are “hypothesis-generating” and that more studies are urgently needed. However, given the scale and clarity of the data, the findings demand attention from public health regulators.
Call for Transparency and Action
Dr. Campbell strongly criticizes the failure of vaccine trials to assess reproductive health impacts before emergency authorizations were granted:
“This wasn’t even considered in the pre-authorization trials. It should have been.”
The Czech Republic remains one of the few countries that collects and publishes this level of linked birth and vaccination data. Dr. Campbell urges other governments and scientific bodies to replicate similar studies and confront the possibility of long-term fertility consequences.
Final Thoughts
The implications of this research are global and deeply concerning.
If the patterns observed in the Czech Republic are echoed elsewhere, it could mark a pivotal moment in how mRNA vaccines are evaluated, particularly for women of childbearing age.